Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Gynecologic 1

Conditions

Overweight 1Obesity 1Neoplasms 1Endometrial Neoplasms 1Endometrial Hyperplasia 1

Interventions

Exercise 24Metformin 19Tirzepatide 9Resistance Training 8Nutrition Assessment 8Methods 8Diet Therapy 8Diet 8Counseling 7Surveys and Questionnaires 6semaglutide 5Liraglutide 5Exenatide 5Early Intervention, Educational 5Diet, Mediterranean 5Caloric Restriction 5Blood Specimen Collection 5Educational Status 4Bariatric Surgery 4Vitamin D 3Sugars 3Standard of Care 3Naltrexone 3Letrozole 3Docosahexaenoic Acids 3Dexamethasone 3Bupropion 3exemestane 2bupropion hydrochloride, naltrexone hydrochoride drug combination 2Yoga 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Obesity × Estrogen Replacement Therapy × Clear all
NCT07462663 2026-05-13

SHAPE-ENDO

Hospital Universitari de Bellvitge

Phase 4 Not yet recruiting
82 enrolled
GynecologicOther

Endometrial Hyperplasia, Neoplasms, Obesity, Endometrial Neoplasms, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡